Eli Lilly director Jon R. Moeller gets 168-share award
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Eli Lilly & Co. director Jon R. Moeller acquired 168 shares of common stock through a grant or award on November 16, 2026. His reported direct holdings after the transaction were 473 shares.
Insider Trade Summary
Grant/Award: 167.6364 shares
Grant/Award
1 txn
Insider
Moeller Jon R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 167.6364 | $1,431.67 | $240K |
Holdings After Transaction:
Common Stock — 473.021 shares (Direct)
Holdings Before and After:
Common Stock, 305.3846 to 473.021 shares (Direct)
Key Figures
Award shares: 168 shares
Reported transaction price: $1,431.67 per share
Direct holdings after transaction: 473 shares
3 metrics
Award shares
168 shares
Grant or award acquisition on November 16, 2026
Reported transaction price
$1,431.67 per share
Grant or award acquisition on November 16, 2026
Direct holdings after transaction
473 shares
Reported following the November 16, 2026 grant or award
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Jon R. Moeller's LLY holdings after the stock award?
Jon R. Moeller reported direct holdings of 473 shares of common stock after the grant or award on November 16, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.